Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes

NCT01652716 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

377

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Exenatide once weekly suspension
DRUG: Exenatide twice daily

Sponsor

AstraZeneca